Dermata Therapeutics Financial Overview
Dermata Therapeutics's market cap is currently $2.20M. The company's EPS TTM is $-1.65; its P/E ratio is -0.11; Dermata Therapeutics is scheduled to report earnings on November 14, 2025, and the estimated EPS forecast is $-1.54. See an overview of income statement, balance sheet, and cash flow financials.
